Abstract 301P
Background
This study aimed to investigate the clinical implications of desaturation during the 6-min walk test (6MWT) for postoperative cardiopulmonary complications in non-small cell lung cancer (NSCLC) patients with moderately decreased lung function.
Methods
Between January 2010 and December 2019, 312 patients whose predicted postoperative value of forced expiratory volume in 1 second (ppoFEV1) or diffusing capacity of carbon monoxide (ppoDLco) were <60% while both were ≥ 30% and who had undergone lobectomy for NSCLC without induction treatment were included this study. Patients were classified into two groups based on the presence of oxygen desaturation (SpO2 <90%) during the 6MWT, and the prevalence and risk of cardiopulmonary complications were evaluated.
Results
Overall, 39 (12.5%) patients desaturated during the 6MWT. The prevalence of cardiopulmonary complications (48.7%, p = 0.007) and pulmonary complications (33.3%, p = 0.017) was significantly higher in patients who desaturated during the 6MWT than in those who did not. However, there was no significant difference in the incidence of postoperative cardiac complications between the two groups. In multivariable-adjusted analyses, the adjusted odds ratio for postoperative cardiopulmonary complications in patients who desaturated during the 6MWT was 2.34 (95% confidence interval = 1.16–4.75) compared to those who did not.
Conclusions
Oxygen desaturation during the 6MWT significantly increased the risk of post-lobectomy cardiopulmonary complications among lung cancer patients with moderately decreased lung function. Our study suggests that oxygen desaturation during the 6WMT could provide additional information when stratifying the postoperative surgical risks in NSCLC patients.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
291P - Assessment of nutritional status in cancer patients using patient generated subjective global assessment screening tool
Presenter: Anuj K. C.
Session: Poster viewing 04
293P - Generic dabigatran for cancer-associated venous thromboembolism: Real-world data
Presenter: Fen Saj
Session: Poster viewing 04
294P - Cross-sectional analysis on cancer-related distress, belief in alternative medicine among cancer patients and attendants visiting a tertiary care center in Northern India
Presenter: Amit Sehrawat
Session: Poster viewing 04
296P - Osimertinib as adjuvant therapy in patients (pts) with resected EGFR-mutated (EGFRm) stage IB-IIIA non-small cell lung cancer (NSCLC): Updated results from ADAURA
Presenter: Yi-Long Wu
Session: Poster viewing 04
297P - Transbronchial microwave ablation of early lung cancers and lung oligometastases: Mid-term results
Presenter: Joyce Chan
Session: Poster viewing 04
298P - Does trisegmentectomy have functional benefit over lobectomy? Comparative analysis of changes in lung function and volumetry among stage IA non-small cell lung cancer patients
Presenter: sumin shin
Session: Poster viewing 04
299P - Furmonertinib as adjuvant therapy in EGFR-mutated non-small cell lung cancer following radical lung cancer surgery
Presenter: Qingyi Zhang
Session: Poster viewing 04
300P - Real-world efficacy and safety of anlotinib in combination with PD-1/PD-L1 inhibitors as first-line or second-line treatment in advanced non-small cell lung cancer
Presenter: Xin Shang
Session: Poster viewing 04
302P - Treatment patterns in resectable early-stage NSCLC in Taiwan: Subgroup analysis of a global real-world study
Presenter: Jin-Yuan Shih
Session: Poster viewing 04